Home | Privacy | Contact    

Information About Multiple Myeloma


Multiple myeloma - Wikipedia, the free encyclopedia
http://en.wikipedia.org/wiki/Multiple_myeloma Multiple myeloma (from Greek myelo-, bone marrow), also known as plasma cell myeloma or Kahler's disease (after Otto Kahler), is a cancer of plasma cells, a type of ... more...
Multiple myeloma - PubMed Health - National Center for ...
http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001609/ Causes, incidence, and risk factors. Plasma cells help your body fight infection by producing proteins called antibodies. In multiple myeloma, plasma cells ... more...
Multiple myeloma - MayoClinic.com - Mayo Clinic
http://www.mayoclinic.com/health/multiple-myeloma/DS00415 Multiple myeloma — Comprehensive overview covers symptoms and treatment of cancer of your plasma cells. more...
Multiple Myeloma Symptoms, Treatment, Stages, Causes and Diagnosis ...
http://www.medicinenet.com/multiple_myeloma/article.htm Multiple myeloma symptoms include bone and rib pain, weight loss, fever and nausea. Read about causes, diagnosis, staging, treatment side effects and research ... more...
multiple myeloma: Definition from Answers.com
http://www.answers.com/topic/multiple-myeloma Library > Literature & Language > Dictionary n. A malignant proliferation of plasma cells in bone marrow causing numerous tumors and characterized by the presence of ... more...



Multiple Myeloma News


multiple myeloma - Bing News
IMPORTANT: Bing News RSS feed has moved!
Go to the new RSS page and renew your subscription.
read more...
35th Annual Empire State Building Run-Up Powered by the MMRF Raises Funds for
A wave of 100 runners for the read more...
Onyx Pharmaceuticals Completes Enrollment in ASPIRE Phase 3 Carfilzomib Combination Trial for the Potential Treatment of Relapsed
SOUTH SAN FRANCISCO, Calif., Feb. 22, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it has reached the target enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination ... read more...

read more...
KATHY GIUSTI SPEAKS AS PART OF THE WELCH MBA FORUM
Diagnosed with read more...